-
2023-504322-19-00
5
2024-01-10
Patients in the intensive care unit on ventilation with pneumonia and
-
2022-502046-28-00
5
2023-12-22
HER2-Positive, PIK3CA Mutated, Locally Advanced or Metastatic Breast C
-
2024-512881-32-00
6
2023-11-22
Psoriasis vulgaris and/or psoriatric arthritis
-
2022-502332-39-00
4
2023-11-15
Tuberous sclerosis complex (TSC)
-
2023-503582-35-00
6
2023-10-26
Staphylococcus aureus bacteremia
-
2023-503661-28-00
5
2023-10-26
Hidradenitis Suppurativa
-
2023-503558-10-00
5
2023-10-13
oligometastatic pancreatic cancer
-
2022-501944-14-00
5
2023-10-02
Patients after gastrectomy (total and partial)
-
2022-501515-14-00
5
2023-09-29
Newly Diagnosed Multiple Myeloma (NDMM)
-
2024-512320-11-00
5
2023-08-09
Primary diffuse large B-cell lymphoma of the central nervous system
(P
-
2024-517966-40-00
4
2023-07-13
Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::ABL1 positive (Ph
-
2023-506716-41-00
9
2023-05-08
Adult patients with advanced (metastatic or unresectable) KRAS G12C
mu
-
2022-501238-52-00
10
2023-03-23
Heart failure due to systemic left ventricular systolic dysfunction
-
2024-511219-78-00
5
2023-02-28
epithelial ovarian cancer
-
2024-515924-35-00
6
2023-01-16
New-Onset Post-Operative Atrial Fibrillation after CABG
-
2022-500783-35-00
5
2022-12-06
Acute Myeloid Leukemia
-
2024-517382-17-00
4
2022-11-30
Newly Diagnosed Multiple Myeloma in patients eligible for stem cell tr
-
2024-514139-50-00
5
2022-11-14
Multiple myeloma
-
2022-500764-35-00
6
2022-10-13
Patients with advanced HER2-negative, hormone receptor positive (HER2n
-
2022-500107-50-00
6
2022-10-12
hilar cholangiocarcinoma
-
2023-507461-26-00
5
2022-09-22
Newly diagnosed acute myeloid leukemia (AML)
-
2023-507557-16-00
5
2022-08-31
chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive
-
2022-501180-40-00
5
2022-06-17
Ewing Sarcoma
-
2023-507119-36-00
5
2022-05-09
Malignant melanoma of the skin in patients with locally advanced and f